糖蛋白130
肿瘤抑制因子
生物
白细胞介素-6受体
白血病抑制因子
分子生物学
受体
信号转导
白细胞介素10受体,α亚单位
白细胞介素12受体,β1亚单位
睫状神经营养因子
单克隆抗体
细胞生物学
白血病抑制因子受体
白细胞介素6
细胞因子
免疫学
白细胞介素-21受体
蛋白质亚单位
抗体
Gα亚单位
生物化学
神经营养因子
车站3
基因
作者
Maryvonne Fourcin,Sylvie Chevalier,Jean‐Jacques Lebrun,Paul A. Kelly,A Pouplard,John Wijdenes,Hugues Gascan
标识
DOI:10.1002/eji.1830240143
摘要
The recently cloned interleukin (IL)-11 displays many biological properties in common with those reported for IL-6. In order to analyze the nature and the functionality of the IL-11 receptor we developed a proliferative assay using the human multifactor-dependent cell line TF1. We showed that a blocking monoclonal antibody GPX7 raised against the gp130/IL-6 receptor transducing subunit was also able to inhibit the IL-11-triggered TF1 line proliferation. In addition, involvement of gp130 in IL-11 signaling was demonstrated by an induction of the transducing protein phosphorylation in response to IL-11, as observed for IL-6. In contrast, the blocking monoclonal antibody B-R6, which recognized the gp80/IL-6 binding subunit failed to interfere with the IL-11 proliferative signal in the TF1 cell line. Similarly, we did not observe any competition between IL-6 and IL-11 for a putative common binding site on the cell surface. These results suggest that the IL-11 binding component is different from the gp80/IL-6 receptor. In conclusion, IL-11, along with IL-6, leukemia inhibitory factor, oncostatin M and ciliary neurotrophic factor, belongs to the same family of cytokines, using gp130 as a transducing protein.
科研通智能强力驱动
Strongly Powered by AbleSci AI